Mirae Asset Global Investments Co., Ltd. Alkermes Plc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,052 shares of ALKS stock, worth $135,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,052

Previous 85,222 94.07%

Holding current value

$135,696

Previous $2.31 Million 94.75%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$23.21 - $27.24 $1.86 Million - $2.18 Million	-80,170 Reduced 94.07%	5,052 $121,000
Q1 2024 May 01, 2024	SELL	$26.4 - $32.56 $161,330 - $198,974	-6,111 Reduced 6.69%	85,222 $2.31 Million
Q4 2023 Jan 24, 2024	BUY	$23.37 - $28.68 $85,767 - $105,255	3,670 Added 4.19%	91,333 $2.53 Million
Q3 2023 Oct 26, 2023	BUY	$27.17 - $31.97 $108,381 - $127,528	3,989 Added 4.77%	87,663 $2.46 Million
Q2 2023 Aug 10, 2023	SELL	$28.34 - $33.63 $24,287 - $28,820	-857 Reduced 1.01%	83,674 $2.62 Million
Q1 2023 May 04, 2023	BUY	$25.31 - $29.02 $267,020 - $306,161	10,550 Added 14.26%	84,531 $2.38 Million
Q4 2022 Feb 09, 2023	BUY	$21.94 - $26.24 $20,886 - $24,980	952 Added 1.3%	73,981 $1.93 Million
Q3 2022 Nov 10, 2022	BUY	$22.0 - $31.87 $567,710 - $822,405	25,805 Added 54.64%	73,029 $1.63 Million
Q2 2022 Jul 26, 2022	BUY	$26.4 - $30.54 $1.18 Million - $1.36 Million	44,615 Added 1710.04%	47,224 $1.41 Million
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $48,997 - $65,616	2,609 New	2,609 $64,000
Q1 2021 May 13, 2021	SELL	$18.21 - $23.2 $185,359 - $236,152	-10,179 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.39 - $22.1 $156,654 - $224,955	10,179 New	10,179 $203,000

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.41B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Alkermes Plc. Transaction History